The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEnquest Regulatory News (ENQ)

Share Price Information for Enquest (ENQ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.06
Bid: 14.90
Ask: 15.02
Change: -0.12 (-0.79%)
Spread: 0.12 (0.805%)
Open: 15.00
High: 15.06
Low: 14.70
Prev. Close: 15.18
ENQ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Demergers Effective and Trading Expected to Begin

6 Apr 2010 07:00

RNS Number : 7181J
EnQuest PLC
06 April 2010
 



**NOT FOR PUBLICATION, DISTRIBUTION OR RELEASEIN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN, SOUTH AFRICA OR AUSTRALIA**

 

 

 

EnQuest PLC

 

Demergers effective and trading expected to commencein shares of EnQuest PLC

 

All of the conditions to the Petrofac Demergerand the Lundin Demerger have been satisfied and the Demergers have become effective.

 

Trading in EnQuest PLC Ordinary Shares under theticker "ENQ.L" is expected to commence on the London Stock Exchange at 8.00 amtoday.

 

CREST accounts of shareholders in Petrofac willbe credited with EnQuest PLC Ordinary Shares at 8.00 am today. In the case of Petrofacshareholders who hold their Petrofac ordinary shares in certificated form, sharecertificates in respect of EnQuest PLC Ordinary Shares will be dispatched to suchshareholders by 19 April 2010.

 

Conditional dealings in EnQuest PLC Ordinary Sharesare expected to commence on NASDAQ OMX Stockholm at 9.00 am CET today under the ticker"ENQ". Unconditional dealings in the Ordinary Shares on NASDAQ OMX Stockholm areexpected to commence on 9 April 2010, the date of Stockholm Admission.

 

Capitalised terms in this announcement are as definedin the Prospectus published by EnQuest PLC on 18 March 2010.

 

- Ends-

 

For further information please contact:

 

J. P. MorganCazenove Tel: +44 (0)20 7588 2828

Bob McGuire

Steve Baldwin

 

Finsbury Tel: +44 (0)20 7251 3801

Andrew Mitchell

Conor McClafferty

Dorothy Burwell

 

 

 

 

 

 

 

Disclaimer

 

 

The information contained in this announcementis for background purposes only and does not purport to be full or complete. No reliancemay be placed for any purpose on the information contained in this announcement orits accuracy or completeness.

 

This announcement is not for publication or distribution,directly or indirectly, in or into the United States. The distribution of this announcementin certain jurisdictions may be restricted by law. Persons into whose possessionthis announcement comes should inform themselves about and observe any restrictionson the distribution of this announcement. Any failure to comply with these restrictionsmay constitute a violation of the securities laws of any such jurisdictions. Personsreceiving this announcement should not distribute or send it into any jurisdictionwhere to do so would or might contravene local securities laws or regulations.

 

This announcement does not constitute or form partof an offer to sell or issue or the solicitation of an offer to subscribe for orbuy, any Ordinary Shares to any person in any jurisdiction to whom or in which suchoffer or solicitation is unlawful and, in particular, is not for distribution orpublication in or into the United States, Canada, Australia, the Republic of SouthAfrica or Japan.

 

The Ordinary Shares have not been and will notbe registered under the US Securities Act of 1933, as amended (the "Securities Act")with any securities regulatory authority or under any securities laws of any stateor other jurisdiction of the United States and may not be taken up, offered, sold,resold, transferred, delivered or distributed, directly or indirectly, within, intoor from the United States except pursuant to an applicable exemption from, or ina transaction not subject to, the registration requirements of the Securities Actand in compliance with any applicable securities laws of any state or other jurisdictionof the United States. There will be no public offer of securities in the UnitedStates.

 

The Ordinary Shares have not been and will notbe registered under the applicable securities laws of Canada, Australia, the Republicof South Africa or Japan and subject to certain exceptions, the Ordinary Shares maynot be offered or sold in Canada, Australia, the Republic of South Africa or Japanor to, or for the account or benefit of, any resident of Canada, Australia, the Republicof South Africa or Japan. There will be no public offer of securities in Canada,Australia, the Republic of South Africa or Japan.

 

J.P. Morgan Securities Ltd. (which conducts itsUK investment banking activities as J.P. Morgan Cazenove), which is authorised andregulated in the United Kingdom by the FSA, is advising the Company and no one else(whether or not a recipient of this announcement) in connection with London Admission.J.P. Morgan Securities Ltd. will not regard any other person (whether or not a recipientof this announcement) as its client in relation to London Admission and will notbe responsible to anyone other than the Company for providing the protections affordedto its clients or for providing advice in relation to London Admission or any othertransaction, arrangement or matter referred to in this announcement.

 

 

None of J.P. Morgan Cazenove, Nordea Markets, RoyalBank of Canada Europe Limited and Oriel Securities Limited or any of their respectivedirectors, officers, employees, advisers or agents accepts any responsibility orliability whatsoever for/or makes any representation or warranty, express or implied,as to the truth, accuracy or completeness of the information in this announcement(or whether any information has been omitted from the announcement) or any otherinformation relating to the Company, its subsidiaries or associated companies, whetherwritten, oral or in a visual or electronic form, and howsoever transmitted or madeavailable or for any loss howsoever arising from any use of announcement or its contentsor otherwise arising in connection therewith.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCIFMATMBJMMRM
Date   Source Headline
17th Dec 201812:22 pmRNSChange of Director's Details
5th Dec 20187:00 amRNSOperations update
3rd Dec 20187:00 amRNSCompletion of Magnus Transaction
26th Nov 201811:56 amRNSDirector/PDMR Shareholding
16th Nov 201812:10 pmRNSHolding(s) in Company
1st Nov 20182:29 pmRNSDirector/PDMR Shareholding
31st Oct 20189:38 amRNSTotal Voting Rights
24th Oct 201812:11 pmRNSDirector/PDMR Shareholding
23rd Oct 20184:47 pmRNSDirector/PDMR Shareholding
22nd Oct 20186:14 pmRNSResults of Rump Placing
22nd Oct 20187:00 amRNSResult of Rights Issue
4th Oct 20187:00 amRNSMagnus and Thistle Options exercised
2nd Oct 20183:12 pmRNSDirector/PDMR Shareholding
2nd Oct 20187:00 amRNSAdmission of Nil Paid Rights
1st Oct 20182:55 pmRNSResults of General Meeting
25th Sep 20187:00 amRNSSwedish Issue Price
24th Sep 20181:43 pmRNSDirector/PDMR Shareholding
7th Sep 20187:00 amRNSMagnus Acquisition and Rights Issue
7th Sep 20187:00 amRNSHalf-year Report
29th Aug 20187:00 amRNSKraken FPSO settlement agreement
31st Jul 20182:17 pmRNSNotice to holders of the Company's Retail Notes
7th Jun 201811:24 amRNSReport on Payments to Govts
24th May 20184:39 pmRNSResult of AGM
24th May 20187:00 amRNSOperations Update
27th Apr 20184:37 pmRNSDirector/PDMR Shareholding
24th Apr 20182:27 pmRNSDirector/PDMR Shareholding
19th Apr 20184:00 pmRNSNotice of AGM and Report & Accounts
29th Mar 20188:57 amRNSDirector/PDMR Shareholding
20th Mar 20187:00 amRNSFull Year Results
21st Feb 20183:56 pmRNSAdmission to Trading
19th Feb 20187:00 amRNSOperations Update
16th Feb 20184:51 pmRNSReplacement: Released in Error
15th Feb 20189:07 amRNSPublication of Final Terms
31st Jan 20187:00 amRNSAGREEMENT WITH BP ON THISTLE DECOMMISSIONING
29th Jan 201810:22 amRNSNotice to holders of the Company's Retail Notes
25th Jan 20183:34 pmRNSHolding(s) in Company
10th Jan 20183:59 pmRNSTotal Voting Rights
8th Jan 20187:00 amRNSBoard Appointment
11th Dec 20177:00 amRNSDirectorate Change
1st Dec 20177:00 amRNSCompletion of Acquisition
30th Nov 20177:00 amRNSOperational Update
26th Oct 20177:00 amRNSLiquidity enhanced by over $100 million
24th Oct 201710:51 amRNSAllotment and Listing of Shares
26th Sep 20173:02 pmRNSDirector/PDMR Shareholding
22nd Sep 201712:58 pmRNSPublication of a Prospectus
13th Sep 20173:48 pmRNSDirector/PDMR Shareholding
7th Sep 20177:00 amRNSBoard Appointment
7th Sep 20177:00 amRNSHalf Year Results
23rd Aug 20177:00 amRNSOperations update
31st Jul 20174:34 pmRNSNotice to holders of the Company's Retail Notes

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.